Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-29, Stock:PFE, The news for the past five days is as follows:
2018-08-22: NEWS1: Drug Companies Start Keeping Prices in Check to Avoid Government Crackdown.NEWS2: Exact Sciences CEO talks new partnership with Pfizer.NEWS3: Why Exact Sciences, Pure Storage, and Zynga Jumped Today.NEWS4: Why Exact Sciences, Pure Storage, and Zynga Jumped Today.NEWS5: Pfizer, Astellas revise two cancer drug trial protocols to speed up results.NEWS6: Should Alnylam's and Ionis' Investors Be Worried About This Recent IPO?.NEWS7: Should Alnylam's and Ionis' Investors Be Worried About This Recent IPO?.NEWS8: EXAS Soars On Pfizer Deal, MYND Delighted, ADMP Faces FDA In Sep..NEWS9: EXAS Soars On Pfizer Deal, MYND Delighted, ADMP Faces FDA In Sep..NEWS10: Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer.NEWS11: Why Exact Sciences, Pure Storage, and Zynga Jumped Today.NEWS12: Health Care Sector Update for 08/22/2018: EXAS,PFE,ARGX,PHG,SNGX.NEWS13: Health Care Sector Update for 08/22/2018: EXAS,PFE,ARGX,PHG,SNGX.NEWS14: Exact Sciences, Pfizer enter 4-year, $174M co-marketing pact to promote Cologuard.NEWS15: Should Alnylam&apos;s and Ionis&apos; Investors Be Worried About This Recent IPO?.NEWS16: Stocks Open Lower, Turn Mixed As Oil Prices, Retail Stocks Rally.NEWS17: [$$] Exact Sciences Shares Jump 26%.NEWS18: Four stocks to watch in today's blitz.NEWS19: Exact Sciences: Why the Stock Price Is Soaring.NEWS20: Better Buy: GlaxoSmithKline PLC vs. Pfizer.NEWS21: Better Buy: GlaxoSmithKline PLC vs. Pfizer.NEWS22: USMV, ONLN: Big ETF Inflows.NEWS23: USMV, ONLN: Big ETF Inflows.NEWS24: Stocks - Target, La-Z-Boy, Urban Outfitters Soar in Pre-market; Lowe’s Slides.NEWS25: Better Buy: GlaxoSmithKline PLC vs. Pfizer.NEWS26: Why Exact Sciences Stock Is Blasting Higher Today.NEWS27: Why Exact Sciences Stock Is Blasting Higher Today.NEWS28: Exact Sciences surges after marketing deal with Pfizer for cancer test.NEWS29: Why Exact Sciences Stock Is Blasting Higher Today.NEWS30: Exact Sciences shares jump 11% premarket on news of Pfizer collaboration on Cologuard.NEWS31: Exact Sciences signs marketing deal with Pfizer for cancer test.NEWS32: Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®.NEWS33: Exact Sciences Corp. (EXAS) Is Up Sharply On Pfizer Deal.NEWS34: Exact Sciences Corp. (EXAS) Is Up Sharply On Pfizer Deal.NEWS35: Exact Sciences & Pfizer To Co-promote Cologuard.NEWS36: Exact Sciences & Pfizer To Co-promote Cologuard.
2018-08-23: NEWS1: Big Pharma's Big Run Isn't Done.NEWS2: Why Exact Sciences Corporation Stock Is Jumping Again Today.NEWS3: Why Exact Sciences Corporation Stock Is Jumping Again Today.NEWS4: Alecensa Could Boost Roche’s Revenue Growth in 2018 and Beyond.NEWS5: Exact Sciences Inks Cologuard Co-Promotion Deal With Pfizer.NEWS6: Exact Sciences Inks Cologuard Co-Promotion Deal With Pfizer.NEWS7: Pfizer Amends Xtandi Study Protocols to Speed Up Completion.NEWS8: Pfizer Amends Xtandi Study Protocols to Speed Up Completion.NEWS9: Why Exact Sciences Corporation Stock Is Jumping Again Today.NEWS10: Pfizer Amends Xtandi Study Protocols to Speed Up Completion.NEWS11: Exact Sciences Inks Cologuard Co-Promotion Deal With Pfizer.NEWS12: Is the Options Market Predicting a Spike in Pfizer (PFE) Stock?.NEWS13: Is the Options Market Predicting a Spike in Pfizer (PFE) Stock?.NEWS14: The Latest Recommendations for Incyte.NEWS15: Is the Options Market Predicting a Spike in Pfizer (PFE) Stock?.NEWS16: Xtandi Trials: Pfizer and Astella Amend the Protocols.NEWS17: Pfizer's Next Blockbuster Drug Has Big Promise. We'll Find Out Monday How Much..NEWS18: FDA extends EpiPen expiration dates because of shortage.
2018-08-24: NEWS1: Analyzing AstraZeneca’s Financial Performance.NEWS2: Analysts Are Bullish on AstraZeneca Stock in August.NEWS3: Merck, Pfizer to Benefit From Pharma Surge: MS.NEWS4: Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs.NEWS5: Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs.NEWS6: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018.NEWS7: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018.NEWS8: Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs.NEWS9: Exact Sciences Revisited.NEWS10: Exact Sciences Revisited.
2018-08-27: NEWS1: EIDX Awaits Phase II Data, PTX Slumps On Court Ruling, TOCA On Watch.NEWS2: EIDX Awaits Phase II Data, PTX Slumps On Court Ruling, TOCA On Watch.NEWS3: What Happened in the Stock Market Today.NEWS4: What Happened in the Stock Market Today.NEWS5: All-Time highs: 6 stocks to buy.NEWS6: Nasdaq Tops 8K as Stocks Celebrate U.S.-Mexico Trade Deal.NEWS7: Nasdaq Tops 8K as Stocks Celebrate U.S.-Mexico Trade Deal.NEWS8: Why Pfizer (PFE) Stock Turned South Today.NEWS9: TLRY On Fire, CRON Up 94% This Month, ALNY Abuzz, RCUS Turns Heads.NEWS10: TLRY On Fire, CRON Up 94% This Month, ALNY Abuzz, RCUS Turns Heads.NEWS11: What Happened in the Stock Market Today.NEWS12: General Motors and Caterpillar jump; Tesla and Pfizer skid.NEWS13: Health Care Sector Update for 08/27/2018: CNC,WMGI,JNJ,PFE.NEWS14: Health Care Sector Update for 08/27/2018: CNC,WMGI,JNJ,PFE.NEWS15: Pfizer Slips Despite Mostly Positive Tafamidis Data; 4 Pharma Stocks Make Sympathy Moves.NEWS16: Here's Why Alnylam Pharmaceuticals and Ionis Pharmaceuticals Jumped Today.NEWS17: Here's Why Alnylam Pharmaceuticals and Ionis Pharmaceuticals Jumped Today.NEWS18: Health Care Sector Update for 08/27/2018: WMGI,JNJ,PFE.NEWS19: Health Care Sector Update for 08/27/2018: WMGI,JNJ,PFE.NEWS20: Here&apos;s Why Alnylam Pharmaceuticals and Ionis Pharmaceuticals Jumped Today.NEWS21: Dow Movers: PFE, CAT.NEWS22: Dow Movers: PFE, CAT.NEWS23: Pfizer rare-disease drug results lift its shares and those of rival.NEWS24: US STOCKS-Futures rise as trade tensions ease.NEWS25: What AstraZeneca’s Valuation Trend Indicates.NEWS26: Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Results Presented as Late-Breaking Data at the ESC Congress 2018.NEWS27: Pfizer's Potential Blockbuster Heart Drug Boosted by Study.NEWS28: Pfizer rare heart disease drug reduces risk of death by 30 pct in study.NEWS29: EpiPen Shortage Hits Back-to-School Season.
2018-08-28: NEWS1: 3 ETFs for Johnson & Johnson's Healthy Breakout.NEWS2: Pfizer Recalls Children's Advil Recall Due To Overdose Concerns.NEWS3: Pfizer Recalls Children's Advil Recall Due To Overdose Concerns.NEWS4: Why Ionis Pharmaceuticals Stock Is Plummeting Today.NEWS5: Pfizer's Tafamidis Fails to Impress in Cardiomyopathy Study.NEWS6: Pfizer's Tafamidis Fails to Impress in Cardiomyopathy Study.NEWS7: Notable ETF Inflow Detected - IWB, UNH, PFE, CVX.NEWS8: Notable ETF Inflow Detected - IWB, UNH, PFE, CVX.NEWS9: 6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug.NEWS10: 6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug.NEWS11: Pfizer&apos;s Tafamidis Fails to Impress in Cardiomyopathy Study.NEWS12: This Is Like Buying in March 2009 and Knowing What Happens Next.NEWS13: This Is Like Buying in March 2009 and Knowing What Happens Next.NEWS14: 6 Things Alnylam Investors Need to Know About Pfizer&apos;s Next Blockbuster Drug.NEWS15: Pfizer stock drops 2% as positive rare-disease drug results won’t stop competitors.NEWS16: Why Alnylam Pharmaceuticals Stock Rose ~16% Yesterday.NEWS17: Today’s Research Reports on Stocks to Watch: Pfizer and Alnylam Pharmaceuticals.NEWS18: Why Pfizer (PFE) Stock Turned South Today.NEWS19: Why Pfizer (PFE) Stock Turned South Today.

Answer: Rise